Lv1
30 积分 2024-09-27 加入
The development of folate-functionalised palladium nanoparticles for folate receptor targeting in breast cancer cells
4小时前
已完结
The role of ROS in tumour development and progression
1个月前
已完结
Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing
1个月前
已完结
A cuproptosis nanocapsule for cancer radiotherapy
2个月前
已完结
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
4个月前
已完结
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
4个月前
已完结
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
4个月前
已完结
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
4个月前
已完结
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
4个月前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
